|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.392
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.342
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.338
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.337
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.275
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.219
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.198
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.186
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.182
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.171
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.169
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.163
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.149
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.143
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.142
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.136
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.135
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.132
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.131
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.130
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.129
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.129
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.115
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.114
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.110
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.109
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.109
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.107
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.106
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.104
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.104
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.101
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.100
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.096
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.096
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.094
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.092
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.092
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.092
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.090
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.088
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.083
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.083
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.083
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.081
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.081
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.080
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.078
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.078
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.076
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.076
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.075
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.075
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.075
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.075
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.072
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.072
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.069
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.069
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.068
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.067
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.067
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.067
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.066
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.065
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.065
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.064
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.064
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.064
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.063
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.063
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.063
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.061
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.061
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.060
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.060
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.060
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.058
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.057
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
30 |
0.057
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.056
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.055
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.055
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.055
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.055
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.054
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.053
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.053
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.053
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.053
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.052
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.052
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.051
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.051
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.051
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.050
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.050
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.050
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.050
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.049
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.049
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.049
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.049
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.049
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.049
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.049
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.048
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.047
|
|
|
|
defense response to fungus
|
GO:0050832 |
12 |
0.047
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.047
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.047
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.047
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.046
|
|
|
|
regulation of t cell costimulation
|
GO:2000523 |
2 |
0.046
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.046
|
|
|
|
neutrophil mediated cytotoxicity
|
GO:0070942 |
8 |
0.046
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.046
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.046
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.046
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.046
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.045
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.045
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.045
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.044
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.044
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.044
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.044
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.044
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.044
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.044
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.044
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.044
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.043
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.043
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.043
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.043
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.042
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.042
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.042
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.042
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.041
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.041
|
|
|
|
leukotriene biosynthetic process
|
GO:0019370 |
5 |
0.041
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.041
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.041
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.040
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.040
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.040
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.039
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.039
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.039
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.039
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.039
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.038
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.038
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.038
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.038
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.038
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.038
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.038
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.038
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.038
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.038
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.037
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.037
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.036
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.036
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.035
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.035
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.035
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.035
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.035
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.035
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.035
|
|
|
|
nonribosomal peptide biosynthetic process
|
GO:0019184 |
5 |
0.035
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.035
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.034
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.034
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.034
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.034
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.034
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.033
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.033
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.033
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.033
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.033
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.033
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.032
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.032
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.032
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.032
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.032
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.032
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.031
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.031
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.031
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.031
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.031
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.031
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.031
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.031
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.031
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.030
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.030
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.030
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.030
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.030
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.030
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.030
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.030
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.030
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.029
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.029
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.029
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.029
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.029
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.029
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.028
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.028
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.028
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.028
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.028
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.028
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.028
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.028
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.027
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.027
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.027
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.027
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.027
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.027
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.027
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.027
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.026
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.026
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.026
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.026
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.026
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
|
positive regulation of dendritic cell chemotaxis
|
GO:2000510 |
1 |
0.026
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.026
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.026
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.026
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.026
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.025
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.025
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.025
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.025
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.025
|
|
|
|
positive regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000451 |
2 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.025
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.024
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.024
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.024
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.024
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.024
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.024
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.024
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.024
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.024
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.023
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.023
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.023
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.023
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.023
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.023
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.023
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.023
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.023
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.023
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.023
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.023
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.022
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.022
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.022
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.022
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.022
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.022
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.022
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.021
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.021
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.021
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.021
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.021
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.021
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
22 |
0.021
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.021
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.021
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.021
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.020
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.020
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.020
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
|
microglial cell activation involved in immune response
|
GO:0002282 |
1 |
0.020
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.020
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.020
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.020
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.020
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.020
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.020
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.020
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.020
|
|
|
|
eosinophil activation involved in immune response
|
GO:0002278 |
1 |
0.020
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.020
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.020
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.019
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.019
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.019
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.019
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.019
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.019
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.019
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.019
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.019
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.019
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.019
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.019
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.019
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.019
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.019
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.019
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.019
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.019
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.019
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.018
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.018
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.018
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.018
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.018
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.018
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.018
|
|
|
|
neutrophil mediated killing of fungus
|
GO:0070947 |
3 |
0.018
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.018
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.018
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.018
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.018
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.018
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.018
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.017
|
|
|
|
translation
|
GO:0006412 |
93 |
0.017
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.017
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.017
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.017
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.017
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.017
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.017
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.017
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.017
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.017
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.017
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.017
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.017
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.017
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.017
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.017
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.017
|
|
|
|
regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000449 |
3 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.016
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.016
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.016
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.016
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.016
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.016
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.016
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.016
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.016
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.016
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.016
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.016
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.016
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.016
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.016
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.016
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.016
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.016
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.016
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.016
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.016
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.016
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.016
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.016
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.016
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.015
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.015
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.015
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.015
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.015
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.015
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
